Intellectual Property

Three landmark patent applications have been filed to protect the product generations. Significant know-how regarding the optimal design and specification of the FFR catheter has been generated during the development process. This has been reduced to practice and incorporated into a patent application.

Further patents have been filed to protect the core pressure compensation methods and apparatus as well as the improved pressure wire with integrated compensation for pressure drop in the presence of flow.

Clinical References

  1. 1. The PressureWire fractional flow reserve measurement system for coronary artery disease. NICE Medtech innovation briefing. Published: 04 February 2014
  2. 2. Fractional Flow Reserve to Guide Coronary Revascularization. Pijls, Nico H.J. March 2013, Circulation Journal, Vol. 77.
  3. 3. The Crux of Maximum Hyperaemia. The last Remaining Barrier for Routine Use of Fractional Flow Reserve. Tonino, Pils &. 2011, JACC Cardiovascular Interventions.
  4. 4. Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement. al, Yoon et. 2009, Am Heart J, Vol. 157, pp. 1050-6.